Prenatal Intravenous Magnesium at 30-34 Weeks’ Gestation and Neurodevelopmental Outcomes in Offspring

Overview of attention for article published in JAMA: Journal of the American Medical Association, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 22 news outlets
blogs: 6 blogs
twitter: 152 X users

facebook: 1 Facebook page
guideline: 1 clinical guideline source
podcasts: 4 podcasts

Readers on

mendeley: 97 Mendeley

So far, Altmetric has seen 7 posts from 6 blogs.

A Boost for Infant Brain Development

Psychology Today, 10 Jun 2024

The neural mechanisms underlying magnesium sulfate treatment in pregnant individuals expecting a pre-term child.

Actualizaciones de EvidenceUpdates en Neonatología (XXIV): segundo semestre 2023

Pediatría Basada en Pruebas, 03 Jan 2024

Un semestre más - y llevamos 24 ediciones - retornamos con las actualizaciones de EvidenceUpdates en Neonatología, en esta…

Bubble Wrap PLUS – September ’23

Don't Forget the Bubbles, 16 Sep 2023

Can’t get enough of Bubble Wrap? The Bubble Wrap Plus is a monthly paediatric journal club reading list from Anke Raaijmakers…

Prenatal magnesium at 30-34 weeks does not reduce risk of death or cerebral palsy: MAGENTA trial

Physician's Weekly, 16 Sep 2023

Bookmark 1. Efficacy: There was no significant difference in death or cerebral palsy at 2 years between those who received…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 3 additional blog posts.